Rein Therapeutics, Inc. · NASDAQ:RNTX
ADAR1 Capital Management, LLC reported a 5.30% stake in Rein Therapeutics, Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Aug 14, 2026
ADAR1 Capital Management, LLC reported a 5.30% stake in Rein Therapeutics, Inc., 4,500,000 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G).
- Stake
- 5.30%
- Shares
- 4,500,000
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| ADAR1 Capital Management, LLC | 5.30% | 4,500,000 |
| Daniel Schneeberger | 5.30% | 4,500,000 |
Source
Related
- Rein Therapeutics, Inc.
- ADAR1 Capital Management, LLC
- Rein Therapeutics, Inc. shareholders
- Schedule 13G/A · Lynwood Capital Management Inc. · Aug 14, 2026
- Schedule 13G/A · Laurence W. Lytton · Aug 13, 2026
- Schedule 13G/A · Voss Capital, LP · Jul 14, 2026
- Form 4 · Von Rickenbach Josef H · May 28, 2026
- Form 4 · Windsor James Brian · May 13, 2026